ROSCO-CF is an exploratory, phase 2a, randomized, double-blind, placebo-controlled, parallel-group study conducted to assess the safety and efficacy of oral R-roscovitine in chronic Pseudomonas aeruginosa (PA) lung infections in patients with cystic fibrosis (pwCF).
- Project data type: Other
- Scope:
- Monoisolate
- UMR 1078, Genetics, functional genomics and biotechnology